[5-(2,4-difluorophenyl)isoxazol-3-yl]methanol, 95.0%, 1g

3-Piperidin-4-yl-propan-1-ol, 95.0%, 250mg

N-(2-Hydroxy-3-sulfopropyl)-3,5-dimethoxyanilinesodium salt, 95.0%, 250mg

3-[(6-Cyclopropylamino-pyrimidin-4-ylamino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

7-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carbonitrile, 95+%, 1g

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-alaninamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

AEBSF Protease Inhibitor 500g

1-Propanone, 3-(3,4-dimethoxyphenyl)-1-(2-hydroxyphenyl)-, 98%, 100mg

1-N-CBZ-4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)PIPERIDINE, 95.0%, 250mg

2-(tert-Butylcarbonylamino)-6-chlorophenylboronic acid, 98+%, 5g

BENZO[D]ISOXAZOLE-3-CARBOXYLIC ACID METHYL ESTER, 95.0%, 2g

Methyl 5-amino-6-bromonicotinate, 98%, 1g

4-Cyano-2-iodobenzoic acid, 95.0%, 100mg